Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP) PAR13-129; Amended Notice of Meeting, 2227 [2019-01206]

Download as PDF Federal Register / Vol. 84, No. 25 / Wednesday, February 6, 2019 / Notices patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)–RFA–TS–19–001, Identify, Analyze and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS). Date: April 24, 2019. Time: 11:00 a.m.–5:00 p.m., EDT. Place: Teleconference. Agenda: To review and evaluate grant applications. For Further Information Contact: Kimberly Leeks, Ph.D., M.P.H., Scientific Review Official, NCIPC, CDC, 4770 Buford Highway NE, Mailstop F–63, Atlanta, Georgia 30341, Telephone (770) 488–6562, KLeeks@cdc.gov. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–01211 Filed 2–5–19; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention amozie on DSK3GDR082PROD with NOTICES1 Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP) PAR13–129; Amended Notice of Meeting Notice is hereby given of a change in the name of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP) PAR13–129; February 26, 2019, 12:00 p.m.–4:00 p.m., EST which was published in the Federal Register on December 21, 2018 Volume 83, Number 245, page 65675. The meeting is being amended to change the funding opportunity announcement to PAR18–812. The meeting is closed to the public. FOR FURTHER INFORMATION CONTACT: Nina Turner, Ph.D., Scientific Review Officer, Office of Extramural Programs, 1095 Willowdale Road, Morgantown, West Virginia 26506, Telephone: (304) 285–5976; Email: nxt2@cdc.gov. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to VerDate Sep<11>2014 18:09 Feb 05, 2019 Jkt 247001 2227 announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. DEPARTMENT OF HEALTH AND HUMAN SERVICES Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. Request for Nominations of Potential Reviewers To Serve on the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP) [FR Doc. 2019–01206 Filed 2–5–19; 8:45 am] BILLING CODE 4163–18–P Centers for Disease Control and Prevention Notice of request for nominations. ACTION: DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)–DD19–002, The Muscular Dystrophy Surveillance, Tracking, and Research Network(MD STARnet). Dates: April 2–3, 2019. Times: 10:00 a.m.–6:00 p.m., EDT. Place: Teleconference. Agenda: To review and evaluate grant applications. For Further Information Contact: Jaya Raman Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway, Mailstop 80, Atlanta, Georgia 30341, Telephone: (770) 488–6511, kva5@cdc.gov. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–01210 Filed 2–5–19; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00089 Fmt 4703 Sfmt 4703 The Centers for Disease Control and Prevention (CDC) is soliciting nominations for possible membership on the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP) in the National Center for Injury Prevention and Control (NCIPC), the National Center for Environmental Health (NCEH), and the Agency for Toxic Substances and Disease Registry (ATSDR). SUMMARY: Nominations for membership on the NCIPC, NCEH and ATSDR SEPs must be received no later than April 1, 2019. Packages received after this time will not be considered for the current membership cycle. ADDRESSES: All nominations should be mailed to NCIPC Extramural Program Office (ERPO): Centers for Disease Control and Prevention, 4770 Buford Highway, Mailstop F–63, Atlanta, GA 30341, emailed (recommended) to NCIPC_PeerReview@cdc.gov, or faxed to (770) 488–4529. FOR FURTHER INFORMATION CONTACT: Kenneth Roberts, Public Health Analyst, CDC/NCIPC/ERPO, 4770 Buford Highway, Mailstop F–63, Atlanta, GA 30341; Telephone: (404) 498–1427; Email: KRoberts3@cdc.gov. SUPPLEMENTARY INFORMATION: The Disease, Disability, and Injury Prevention and Control Special Emphasis Panel provides advice and guidance to the Secretary, Department of Health and Human Services (HHS); the Director, Centers for Disease Control and Prevention (CDC), and the Administrator, Agency for Toxic Substances and Disease Registry (ATSDR) regarding the concept review, scientific and technical merit of grant and cooperative agreement assistance applications, and contract proposals relating to the causes, prevention, and control of diseases, disabilities, injuries, and impairments of public health significance; exposure to hazardous substances in the environment; health promotion and education; and other related activities that promote health and well-being. Nominations are being DATES: E:\FR\FM\06FEN1.SGM 06FEN1

Agencies

[Federal Register Volume 84, Number 25 (Wednesday, February 6, 2019)]
[Notices]
[Page 2227]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01206]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP) PAR13-129; Amended Notice of Meeting

    Notice is hereby given of a change in the name of the Disease, 
Disability, and Injury Prevention and Control Special Emphasis Panel 
(SEP) PAR13-129; February 26, 2019, 12:00 p.m.-4:00 p.m., EST which was 
published in the Federal Register on December 21, 2018 Volume 83, 
Number 245, page 65675.
    The meeting is being amended to change the funding opportunity 
announcement to PAR18-812.
    The meeting is closed to the public.

FOR FURTHER INFORMATION CONTACT: Nina Turner, Ph.D., Scientific Review 
Officer, Office of Extramural Programs, 1095 Willowdale Road, 
Morgantown, West Virginia 26506, Telephone: (304) 285-5976; Email: 
nxt2@cdc.gov.
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-01206 Filed 2-5-19; 8:45 am]
 BILLING CODE 4163-18-P